Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart Disease.

Autor: Goldman, Lee, Weinstein, Milton C., Goldman, Paula A., Williams, Lawrence W.
Předmět:
Zdroj: JAMA: Journal of the American Medical Association; 3/6/91, Vol. 265 Issue 9, p1145, 7p, 5 Charts
Abstrakt: Presents a study that determined the cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for the primary and secondary prevention of coronary heart disease (CHD), using the Coronary Heart Disease Policy Model (CHDPM). Importance of the serum cholesterol level as a risk factor for CHD; Recommendation on medications for secondary prevention of CHD; Description of the model.
Databáze: Complementary Index